Prof. Virginijus Šikšnys currently holds a chair of distinguished professor at Vilnius University. He also serves as a chief scientist/head of the department at the Institute of Biotechnology of Vilnius University and a chairman of the board of Life Science Center. He is also a founder and chairman of the board of the “Caszyme” company. Prof. Virginijus Šikšnys’s research on the CRISPR-Cas has had a major impact in the field of gene editing.
He together with co-authors, published seminal papers on Cas9 biochemistry that were the foundation for the translation of CRISPR-Cas bacterial immune system into a powerful genome-editing tool. He is a member of EMBO, EAM, Lithuania Academy of Sciences and Norwegian Academy of Sciences and letters. His work has been recently recognized with several awards and prizes including the Kavli Prize.